NCT02229136 Miracle Mouthwash Plus Hydrocortisone vs Prednisolone Mouth Rinse for Mouth Sores Caused by Everolimus Status COMPLETED Phase PHASE2
NCT01837446 Morphine Mouthwash for Management of Oral Mucositis in Patients With Head and Neck Cancer Status COMPLETED Phase PHASE2/PHASE3
NCT01288625 Prospective Study of Head and Neck Cancer Radiation Treatment With or Without Amifostine Status WITHDRAWN Phase PHASE4
NCT01099891 The Clinical Study for Evaluation of Efficacy and Safety of EGF on Oral Mucositis in Radiation Therapy Patients Status UNKNOWN Phase PHASE3
NCT00323518 A Phase II Controlled Trial of Velafermin for Prevention of Oral Mucositis Status COMPLETED Phase PHASE2
NCT00104065 Safety and Efficacy of CG53135-05 in the Prevention of Oral Mucositis in Patients Receiving Bone Marrow Transplant Status COMPLETED Phase PHASE2
NCT00101582 Palifermin for the Reduction of Oral Mucositis in Patients With Locally Advanced Head and Neck Cancer Status COMPLETED Phase PHASE3
NCT00075023 Effectiveness of Topical Thalidomide to Treat Chronic Graft-Versus-Host-Disease Related Stomatitis Status TERMINATED Phase PHASE2
NCT00051441 Safety & Efficacy Study of Benzydamine Oral Rinse for the Treatment of Oral Mucositis (Mouth Sores) Resulting From Radiation Therapy for Cancer of the Oral Cavity, Oropharynx, or Nasopharynx Status COMPLETED Phase PHASE3
NCT00041665 Recombinant Human Keratinocyte Growth Factor to Reduce Oral Mucositis in Hematologic Malignancy Patients Undergoing Peripheral Blood Stem Cell Transplantation After Radiation and High-dose Chemotherapy Status COMPLETED Phase PHASE3
NCT00031551 Evaluation of Efficacy and Mechanisms of an Antiinflammatory Intervention for Chemotherapy Related Mucosal Injury Status TERMINATED Phase PHASE2
NCT00001812 A Randomized, Double-Blind, Placebo Controlled Trial Evaluating the Impact of Nystatin on the Development of Oral Irritation in Patients Receiving High Dose Intravenous Interleukin-2 Status COMPLETED Phase PHASE3